Patents by Inventor Michele Orlando
Michele Orlando has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11915589Abstract: The present invention describes an anti-collision system (1) for ground vehicles, comprising a first transceiver device (4), associated with an obstacle (B), configured to generate and transmit one or more wireless signals (SG_B_i), at pre-established time intervals, the first wireless signal (SG_B_1) carrying an obstacle identification code (ID_1); a second transceiver device (3), associated with a ground vehicle (A), configured to transmit one or more wireless signals (SG_A_i) and to receive said one or more wireless signals (SG_B_i) comprising said first wireless signal (SG_B_1) carrying the obstacle identification code (ID_1); a processing unit (20) configured to process collision data of said vehicle (A) comprising: a first calculation module (21) configured to determine the trajectory (D_TRJ) of the ground vehicle (A) and the obstacle (B) as a function of said wireless signals (SG_B_i) and said wireless signals (SG_A_i); a second calculation module (23) configured to determine on the basis of said trajeType: GrantFiled: July 17, 2020Date of Patent: February 27, 2024Assignee: UBIQUICOM S.R.LInventors: Michele Orlando, Andrea Capolei, Claudio Rosace, Stefano Sarasso
-
Publication number: 20230298415Abstract: The present invention relates to a device (2) for monitoring the transit of a user or of a land vehicle through a passage (or opening, or considerable area, hereinafter referred to cumulatively as “passage” for brevity's sake), comprising: a receiver-transmitter (5) of short-range radio signals configured to: transmit data indicative of a unique recognition code of the passage (ID_2); receive data indicative of a confirmation of receipt of a unique recognition code (ID_1) and indicative of an identifier of a user present inside the set cover angle (3); a processing unit (20) configured to: a) receive a first presence detecting signal (S1) having a value that is indicative of the presence of the user and of the vehicle inside the set cover angle (3) and generate, as a function of the value of the first presence detecting signal (S1), a second signal (S2) that carries data indicative of said unique recognition code (ID_1); b) calculate, with great precision, at set intervals of time (ti), the distance (diType: ApplicationFiled: July 13, 2021Publication date: September 21, 2023Applicant: UBIQUICOM S.R.L.Inventors: Michele ORLANDO, Stefano SARASSO
-
Publication number: 20220292973Abstract: The present invention describes an anti-collision system (1) for ground vehicles, comprising a first transceiver device (4), associated with an obstacle (B), configured to generate and transmit one or more wireless signals (SG_B_i), at pre-established time intervals, the first wireless signal (SG_B_1) carrying an obstacle identification code (ID_1); a second transceiver device (3), associated with a ground vehicle (A), configured to transmit one or more wireless signals (SG_A_i) and to receive said one or more wireless signals (SG_B_i) comprising said first wireless signal (SG_B_1) carrying the obstacle identification code (ID_1); a processing unit (20) configured to process collision data of said vehicle (A) comprising: a first calculation module (21) configured to determine the trajectory (D_TRJ) of the ground vehicle (A) and the obstacle (B) as a function of said wireless signals (SG_B_i) and said wireless signals (SG_A_i); a second calculation module (23) configured to determine on the basis of said trajeType: ApplicationFiled: July 17, 2020Publication date: September 15, 2022Applicant: UBIQUICOM S.R.L.Inventors: Michele ORLANDO, Andrea CAPOLEI, Claudio ROSACE, Stefano SARASSO
-
Patent number: 8916518Abstract: The invention relates to a method for coupling proteins to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the protein is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the protein which reacts with the aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: GrantFiled: May 28, 2009Date of Patent: December 23, 2014Assignee: Fresenius Kabi Deutschland GmbHInventors: Jurgen Hemberger, Michele Orlando, Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Katharina Lutterbeck, Cornelius Jungheinrich, Roland Scharpf
-
Patent number: 8840879Abstract: Conjugates of hydroxyalkyl starch and a protein are provided herein. The conjugates are formed by a covalent linkage between the hydroxyalkyl starch or a derivative of the hydroxyalkyl starch and the protein. Methods of producing the conjugates and the use of the conjugates also are provided herein.Type: GrantFiled: February 1, 2011Date of Patent: September 23, 2014Assignee: Fresenius Kabi Deutschland GmbHInventors: Wolfram Eichner, Martin Schimmel, Frank Hacket, Elmar Kraus, Norbert Zander, Ronald Frank, Harald Conradt, Klaus Langer, Michele Orlando, Klaus Sommermeyer
-
Patent number: 8466277Abstract: The invention relates to a method for coupling low-molecular weight substances to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the low-molecular weight substance is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the low-molecular weight substance which reacts with this aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of said conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: GrantFiled: February 28, 2003Date of Patent: June 18, 2013Assignee: Fresenius Kabi Deutschland GmbHInventors: Michele Orlando, Jurgen Hemberger, Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Katharina Lutterbeck, Cornelius Jungheinrich, Roland Scharpf
-
Patent number: 8287850Abstract: Conjugates of hydroxyalkyl starch and a protein are provided. The conjugates are formed by a reductive amination reaction between at least one aldehyde group or keto group or hemiacetal group of the hydroxyalkyl starch or of a derivative of the hydroxyalkyl starch, and at least one amino group of the protein, so that the hydroxyalkyl starch or the derivative thereof is covalently linked to the protein via an azomethine linkage or a amino linkage. Methods of producing these conjugates and specific uses of the conjugates also are provided.Type: GrantFiled: September 8, 2006Date of Patent: October 16, 2012Assignee: Fresenius Kabi Deutschland GmbHInventors: Wolfram Eichner, Michele Orlando, Norbert Zander, Harald S. Conradt, Frank Hacket, Klaus Langer, Ronald Frank
-
Publication number: 20120259107Abstract: The invention relates to a method for coupling low-molecular substances to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the low-molecular substance is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the low-molecular substance which reacts with this aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of said conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: ApplicationFiled: June 12, 2012Publication date: October 11, 2012Inventors: Michele Orlando, Jurgen Hemberger, Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Katharina Lutterbeck, Cornelius Jungheinrich, Roland Scharpf
-
Patent number: 8017739Abstract: Conjugates of hydroxyalkyl starch and a protein are provided herein. The conjugates are formed by a convalent linkage between the hydroxyalkyl starch or a derivative of the hydroxyalkyl starch and the protein. Methods of producing the conjugates and the use of the conjugates also are provided herein.Type: GrantFiled: September 8, 2006Date of Patent: September 13, 2011Assignee: Fresenius Kabi Deutschland GmbHInventors: Wolfram Eichner, Martin Schimmel, Frank Hacket, Elmar Kraus, Norbert Zander, Ronald Frank, Harald Conradt, Klaus Langer, Michele Orlando, Klaus Sommermeyer
-
Publication number: 20110200555Abstract: Conjugates of hydroxyalkyl starch and a protein are provided herein. The conjugates are formed by a convalent linkage between the hydroxyalkyl starch or a derivative of the hydroxyalkyl starch and the protein. Methods of producing the conjugates and the use of the conjugates also are provided herein.Type: ApplicationFiled: February 1, 2011Publication date: August 18, 2011Applicant: FRESENIUS KABI DEUTSCHLAND GMBHInventors: Wolfram Eichner, Martin Schimmel, Frank Hacket, Elmar Kraus, Norbert Zander, Ronald Frank, Harald Conradt, Klaus Langer, Michele Orlando, Klaus Sommermeyer
-
Patent number: 7816516Abstract: The invention relates to compounds, comprising a conjugate of hydroxyalkyl starch (HAS) and an active agent, whereby the hydroxyalkyl starch is either directly covalently bonded to the active agent, or by means of a linker. The invention further relates to methods for the production of a covalent HAS-active agent conjugate, whereby HAS and an active agent are reacted in a reaction medium, characterised in that the reaction medium is water or a mixture of water and an organic solvent, comprising at least 10 wt. % water.Type: GrantFiled: March 15, 2002Date of Patent: October 19, 2010Assignee: Fresenius Kabi Deutschland GmbHInventors: Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Cornelius Jungheinrich, Roland Scharpf, Katharina Lutterbeck, Jurgen Hemberger, Michele Orlando
-
Publication number: 20090233847Abstract: The invention relates to a method for coupling proteins to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the protein is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the protein which reacts with the aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: ApplicationFiled: May 28, 2009Publication date: September 17, 2009Inventors: Jurgen Hemberger, Michele Orlando, Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Katharina Lutterbeck, Cornelius Jungheinrich, Roland Scharpf
-
Patent number: 7541328Abstract: The invention relates to a method for coupling proteins to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the protein is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the protein which reacts with the aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: GrantFiled: February 28, 2003Date of Patent: June 2, 2009Assignee: Fresenius Kabi Deutschland GmbHInventors: Jurgen Hemberger, Michele Orlando, Klaus Sommermeyer, Wolfram Eichner, Sven Frie, Katharina Lutterbeck, Cornelius Jungheinrich, Roland Scharpf
-
Patent number: 7538092Abstract: The present invention relates to pharmaceutically active oligosaccharide conjugates having the formula: (X—Ym)n—S, wherein component X is a pharmaceutically active compound, Y is a bifunctional linker, and S is an oligosaccharide consisting of 1 to 20 saccharide units, n is equal or less than the number of the saccharide units in the oligosaccharide S, and m is, independent of n, 0 or 1. In addition, the present invention is directed to a process of preparing compounds of the present invention, comprising the step of coupling components X and S directly or indirectly by means of a bifunctional linker group. Furthermore, the present invention relates to the use of said pharmaceutically active oligosaccharide conjugates as a medicament as well as to pharmaceutical compositions, freeze-dried pharmaceutical compositions, and a kit, all of which comprise at least one of said pharmaceutically active oligosaccharide conjugates.Type: GrantFiled: October 8, 2003Date of Patent: May 26, 2009Assignee: Fresenius Kabi Deutschland GmbHInventors: Michele Orlando, Jurgen Hemberger, Jeanne Delbos-Krampe
-
Publication number: 20090047251Abstract: Conjugates of hydroxyalkyl starch and a protein are provided herein. The conjugates are formed by a convalent linkage between the hydroxyalkyl starch or a derivative of the hydroxyalkyl starch and the protein. Methods of producing the conjugates and the use of the conjugates also are provided herein.Type: ApplicationFiled: September 8, 2006Publication date: February 19, 2009Inventors: Wolfram Eichner, Martin Schimmel, Frank Hacket, Elmar Kraus, Norbert Zander, Ronald Frank, Harald Conradt, Klaus Langer, Michele Orlando, Klaus Sommermeyer
-
Publication number: 20070134197Abstract: Conjugates of hydroxyalkyl starch and a protein are provided. The conjugates are formed by a reductive amination reaction between at least one aldehyde group or keto group or hemiacetal group of the hydroxyalkyl starch or of a derivative of the hydroxyalkyl starch, and at least one amino group of the protein, so that the hydroxyalkyl starch or the derivative thereof is covalently linked to the protein via an azomethine linkage or a amino linkage. Methods of producing these conjugates and specific uses of the conjugates also are provided.Type: ApplicationFiled: September 8, 2006Publication date: June 14, 2007Inventors: Wolfram Eichner, Michele Orlando, Norbert Zander, Harald Conradt, Frank Hacket, Klaus Langer, Ronald Frank
-
Publication number: 20060217293Abstract: The invention relates to a method for coupling low-molecular weight substances to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the low-molecular weight substance is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the low-molecular weight substance which reacts with this aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of said conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: ApplicationFiled: February 28, 2003Publication date: September 28, 2006Inventors: Michele Orlando, Jurgen Hemberger
-
Publication number: 20060100163Abstract: The present invention relates to pharmaceutically active oligosaccharide conjugates having the formula: (X—Ym)n—S, wherein component X is a pharmaceutically active compound, Y is a bifunctional linker, and S is an oligosaccharide consisting of 1 to 20 saccharide units, n is equal or less than the number of the saccharide units in the oligosaccharide S, and m is, independent of n, 0 or 1. In addition, the present invention is directed to a process of preparing compounds of the present invention, comprising the step of coupling compounents X and S directly or indirectly by means of a bifunctional linnker group. Furthermore, the present invention relates ot the use of said pharmaceutically active oligosaccharide conjugates as a medicament as well as to pharmaceutical compositions, freeze-dried pharmaceutical compositions, and a kit, all of which comprise at least one of said pharmaceutically active oligosaccharide conjugates.Type: ApplicationFiled: October 8, 2003Publication date: May 11, 2006Inventors: Michele Orlando, Jurgen Hemberger, Jeanne Delbos-Krampe
-
Publication number: 20050267169Abstract: The present invention relates to propofol derivatives comprising a cyclic or linear amino acid, or a poly- or (oligo)saccharide moiety, a process for preparing said derivatives, a method for anesthetizing a mammal as well as a method for treating convulsions, migraine or related diseases, or for the inhibition of free radicals in a mammal to which said compounds are administered. Furthermore, the present invention relates to said compounds for use as a medicament and the use of said compounds for the preparation of a medicament for anesthetizing a mammal or for treating convulsions, migraine or related diseases, or for inhibition of free radicals in a mammal.Type: ApplicationFiled: April 7, 2005Publication date: December 1, 2005Inventors: Michele Orlando, Jurgen Hemberger, Giuseppe Trapani, Gaetano Liso, Cosimo Altomare, Andrea Latrofa, Giovanni Biggio, Mariangela Serra, Enrico Sanna, Valentino Laquintana
-
Publication number: 20050181985Abstract: The invention relates to a method for coupling proteins to a starch-derived modified polysaccharide. The binding interaction between the modified polysaccharide and the protein is based on a covalent bond which is the result of a coupling reaction between the terminal aldehyde group or a functional group of the modified polysaccharide molecule resulting from the chemical reaction of this aldehyde group and a functional group of the protein which reacts with the aldehyde group or with the resulting functional group of the polysaccharide molecule. The bond directly resulting from the coupling reaction can be optionally modified by a further reaction to the aforementioned covalent bond. The invention further relates to pharmaceutical compositions that comprise conjugates formed in this coupling process and to the use of said conjugates and compositions for the prophylaxis or therapy of the human or animal body.Type: ApplicationFiled: February 28, 2003Publication date: August 18, 2005Inventors: Jurgen Hemberger, Michele Orlando